艾司西酞普兰对冠心病伴焦虑、抑郁患者炎症因子水平及血管内皮功能的影响

doi:10.3969/j.issn.1671-7171.2024.03.029

Abstract
Figure/Table
References (0)
Related Citation (15)

Download: PDF (1186 KB) HTML (1 KB)
Export: BibTeX | EndNote (RIS)

Abstract 【Objective】To investigate the effect of escitalopram on the levels of inflammatory factors and vascular endothelial function in patients with coronary heart disease accompanied by anxiety and depression. 【Methods】A total of 112 patients with coronary heart disease accompanied by anxiety and depression admitted to two hospitals from July 2021 to July 2022 were selected and randomly divided into an observation group and a control group according to a random number table method, with 56 cases in each group. The control group was given conventional drug treatment, while the observation group was treated with escitalopram on the basis of the control group. The vascular endothelial function [endothelin-1(ET-1), vascular endothelial growth factor(VEGF), nitric oxide(NO)], inflammatory factors [interleukin-2(IL-2), C-reactive protein(CRP), interleukin-8(IL-8), tumor necrosis factor-α(TNF-α)], neurotransmitters [brain-derived neurotrophic factor(BDNF), norepinephrine(NE), serotonin(5-HT)], cognitive function [Loewenstein Cognitive Assessment Rating Scale(LOTCA) score], Hamilton Depression Rating Scale(HAMD) score, and Hamilton Anxiety Rating Scale(HAMA) score were compared before and after treatment between the two groups. 【Results】After treatment, the levels of ET-1, TNF-α, IL-8, CRP, and IL-2 in the observation group were lower than those in the control group, while NO and VEGF were higher than those in the control group(P<0.05). After treatment, the levels of BDNF, NE, and 5-HT in the observation group were higher than those in the control group(P<0.05). After treatment, the LOTCA scores and total scores in the observation group were higher than those in the control group(P<0.05). After treatment, the HAMD and HAMA scores in the observation group were lower than those in the control group(P<0.05). 【Conclusion】Escitalopram has significant effect on improving negative emotions in patients with coronary heart disease accompanied by anxiety and depression, which can reduce the inflammatory response and improve vascular endothelial function.

Key words： Coronary Disease/CO Anxiety/CO Depression/CO Chemokines/BL Endothelium, Vascular

Received: 25 June 2023

PACS:

R541.4

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	WANG Wenfeng
	DING Shoukun

Cite this article:

WANG Wenfeng,DING Shoukun. The Effect of Escitalopram on the Level of Inflammatory Factors and Endothelial Function in Patients with Coronary Heart Disease Accompanied by Anxiety and Depression[J]. JOURNAL OF CLINICAL RESEARCH, 2024, 41(3): 424-426.

URL:

http://journal07.magtech.org.cn/yxlcyj/EN/10.3969/j.issn.1671-7171.2024.03.029 OR http://journal07.magtech.org.cn/yxlcyj/EN/Y2024/V41/I3/424

[1] 曹俊花,姚爱萍.钙通道阻滞剂联合阿司匹林治疗冠心病对患者心功能和症状的改善价值[J].中国药物与临床,2021,21(4):565-568.
[2] 中国心血管健康与疾病报告编写组.中国心血管健康与疾病报告2021概要[J].中国循环杂志,2022,37(6):553-578.
[3] 石炜祺,刘如辉,倪奕,等.冠心病伴焦虑抑郁患者的临床特点研究[J].中国全科医学,2019,22(18):2166-2171.
[4] 张恩圆,刘园园,吴雪,等.芪参益气滴丸在冠心病支架置入术后合并抑郁及焦虑患者中的应用[J].中国心血管病研究,2022,20(11):978-983.
[5] 陈昌海,李良明.地奥心血康软胶囊治疗冠心病伴焦虑、抑郁的疗效观察[J].中西医结合心脑血管病杂志,2022,20(21):4024-4027.
[6] 中国心血管病预防指南(2017)写作组,中华心血管病杂志编辑委员会.中国心血管病预防指南(2017)[J].中华心血管病杂志,2018,46:10-25.
[7] 美国精神医学学会.美国精神障碍诊断与统计手册[M].张道龙,译.北京:人民卫生出版社,2014.
[8] 王启辉,陈丽霞,王思洋,等.草酸艾司西酞普兰对冠心病伴焦虑抑郁患者负性情绪及心功能的影响[J].实用心脑肺血管病杂志,2019,27(11):85-88.
[9] 安莹,侯季秋,陈雅丽,等.抗抑郁药对冠心病合并抑郁患者疗效及炎症因子影响的Meta分析[J].中国现代医学杂志,2021,31(3):84-91.
[10] 李刚,刘晓东.艾司西酞普兰治疗老年冠心病介入术后抑郁症状的效果及对血浆5-HT、BDNF、NE水平的影响[J].河北医药,2022,44(18):2790-2793.
[11] 刘春萍,崔振双.冠状动脉粥样硬化性心脏病合并焦虑抑郁的临床诊疗策略[J].中国临床医生杂志,2022,50(4):385-387.
[12] 古智文,黄雄,陈丽萍,等.电针联合艾司西酞普兰对重性抑郁障碍患者认知功能及血清炎症因子的影响[J].山东中医杂志,2021,40(9):972-976.
[13] 邵静.通心络胶囊对冠心病介入术后患者疗效及对血管内皮功能和炎症因子影响研究[J].贵州医药,2022,46(2):294.
[14] 林烨,周建华,焦红军.艾司西酞普兰联合降脂药物对老年冠心病患者抑郁情绪及血脂、血清相关因子表达水平的影响[J].国际精神病学杂志,2022,49(4):659-661.